Michael Celano
Secretary & CFOMr. Michael Celano, also known as Mike, CPA, serves as Chief Financial Officer at Larimar Therapeutics, Inc. since May 28, 2020 and also serves as its Secretary. He had been Independent Chairman of OraSure Technologies, Incorporation since April 1, 2018 until November 08, 2022. He served as the Chief Financial Officer of The Columbus Organization since January 2020. From May 2019 to January 2020, Mr. Celano performed consulting work. He served as Chief Operating Officer at Recro Pharma, Inc. since January 2018 until May 09, 2019. He had been Secretary at Recro Pharma, Inc. since March 2018. Mr. Celano was the Chief Financial Officer of Recro Pharma, Inc. from July 2016 to January 2018. Between 2015 and June 2016 Mr. Celano was self-employed providing consulting services to healthcare companies. Mr. Celano has served in a Part-Time capacity, as the Chief Financial Officer of Makindus since 2015. He has several years of financial leadership experience in the life sciences and biopharmaceutical industries. He served as the Chief Financial Officer of DrugScan, a laboratory services company from 2013 to 2015. He served as the Chief Financial Officer of Kensey Nash Corporation from March 10, 2009 to 2012. He served as Managing Director of Life Sciences National Practice Group at Aon Risk Services Companies, Inc. from August 2007 to December 2008. He served as the Chief Financial Officer and Vice President of Finance at BioRexis Pharmaceuticals Corporation, a biopharmaceutical company from July 2004 to May 2007. He has extensive experience in life sciences where he spent several years in public accounting as a Partner with KPMG LLP, where he was an in charge of its Mid-Atlantic Life Sciences Practice from June 2002 to August 2004 and was a Co-Leader of its National Life Science Practice. Prior to joining KPMG, he was Co-Leader of the Life Science Practice and Partner for Arthur Andersen LLP for several years. He served more than forty life sciences clients and was the Lead Audit Partner for sixteen different public life sciences companies. From 1980 to 2004, he worked at Arthur Andersen/KPMG. He was the Lead Partner on twenty-two initial public offerings. He worked on over 100 public offerings and over sixty corporate Partner and merger/acquisition transactions. He has been a Director of Performance Health Holdings Corp. since September 2015. He had been an independent Director of OraSure Technologies, Inc. since October 2006 until November 08, 2022. He serves on the Board of a publicly held medical diagnostics company. He served as a Board Member of the Greater Philadelphia Venture Group. He is a Co-Founder and Advisor of the Philadelphia/Princeton Chapter of the Association of Bioscience Financial Officers. He served as Treasurer of The Pennsylvania Biotechnology Association. From 2003 to 2004, he served as the Chairman of the National Conference for the Association of Bioscience Financial Officers. He served as the Chairman of the Mid-Atlantic Venture Conference (the First Non-Venture Capital/Investment Banker to Chair the conference). He served as a Director of The Pennsylvania Biotechnology Association. Mr. Celano is a Certified Public Accountant and holds a B.S. degree in Accounting from St. Joseph’s University.
Positions
- Company NameLarimar Therapeutics, Inc.Stock CodeLRMRPositionSecretary & CFOColleagues
- CSCarole S. Ben-MaimonCEO & Director
- JTJoseph TruittIndependent Chairman of the Board
- GSGopi ShankarChief Development Officer
- JBJohn B. HarlowPresident & COO
- JBJohn BermanVice President of Finance & Administration
- JSJonathan S. LeffIndependent Director
- FEFrank Edward ThomasIndependent Director
- TEThomas Edward HamiltonIndependent Director
